7 completed. 4 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 3 |
Follow Seasonique: new trials by email Literature Review of Seasonique trials Research Report on Seasonique
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women 91-day Levonorgestrel Oral Contraceptive, 28-day Levonorgestrel Oral Contraceptive, 28-day Desogestrel Oral Contraceptive - Hemostasis, Oral Contraceptive | Phase 2 | Completed | Teva Women's Health | 265 | 2010-11-01 | 2015-03-13 |
| A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females 91-day Levonorgestrel Oral Contraceptive, 28-day Levonorgestrel Oral Contraceptive - Bone Mineral Density | Phase 2 | Completed | Duramed Research | 1361 | 2009-06-01 | 2014-10-22 |
| A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches 91-day Levonorgestrel Oral Contraceptive, Placebo - Migraine | Phase 2 | Completed | Duramed Research | 109 | 2009-01-01 | 2017-02-06 |
| A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)], Seasonique (LNG/EE and EE), Portia (LNG/EE) - Healthy | Phase 3 | Completed | Duramed Research | 36 | 2005-06-01 | 2014-05-09 |
| A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, Placebo tablet - Dysmenorrhea | Phase 2 | Completed | Duramed Research | 95 | 2005-05-01 | 2016-09-22 |
| A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, levonorgestrel/EE 0.15/0.03 mg tablets and placebo - Dysmenorrhea | Phase 3 | Completed | Duramed Research | 97 | 2005-01-01 | 2014-05-12 |
| A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive. Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets - Contraception | Phase 3 | Completed | Duramed Research | 320 | 2003-05-01 | 2014-04-08 |
Dysmenorrhea (2) · Migraine Disorders (1) · Thrombosis (1)
Duramed Research (6) · Teva Women's Health (1)
United States (7) · Italy (1)
Jen Henrick (1)